The National Blood Clot Alliance is thrilled to welcome two new members to its Board of Directors, Kakneka D. Mason, Pharm.D, BCPS, and Justin Crockett, DHA.
Dr. Mason is a medical affairs professional in the pharmaceutical industry. In this role, she is a liaison for her company and the medical community. She also has extensive experience as a clinical pharmacist. Dr. Mason suffered a blood clot due to the use of oral contraceptives and joined NBCA as a Community Thrombassador in 2021, where she aims to raise awareness and education about life-threatening blood clots, especially as it relates to underserved minorities and athletes. Dr. Mason holds a Doctor of Pharmacy degree from the Virginia Commonwealth University School of Medicine. She resides in Columbia, Maryland.
Dr. Crockett has spent 20 years working in the medical device field, focusing on patient preferences and patient pathways in healthcare systems. He has been employed with St. Jude Medical, Boston Scientific, and Inari Medical. Currently, Dr. Crockett teaches at New York University’s Wagner Graduate School of Public Service. His doctoral research has led to the development of the first VTE Coordinator Academy for healthcare providers. Dr. Crockett holds an MBA from the University of Southern Mississippi and a Doctor of Health Care Administration from the Medical University of South Carolina. He resides in Oxford, Mississippi.
Board Chair Teresa Bordeaux said that Dr. Mason’s pharmacy background and Dr. Crockett’s work in the medical device space will broaden the Board’s expertise to better serve the blood clot community.
“We are beyond excited to welcome Drs. Mason and Crockett to the Board,” Teresa said. “They will bring fresh perspectives, diverse experiences, and innovative ideas that can help us continue to move the mission forward.”
More about the NBCA Board of Directors.
